Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer.
Wondergem M, Jansen BHE, van der Zant FM, van der Sluis TM, Knol RJJ, van Kalmthout LWM, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN. Wondergem M, et al. Among authors: van der zant fm, van der sluis tm, van kalmthout lwm, van moorselaar rja. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1911-1918. doi: 10.1007/s00259-019-04385-6. Epub 2019 Jun 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31230088 Free PMC article.
Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry.
Kuppen MCP, Westgeest HM, van den Eertwegh AJM, van Moorselaar RJA, van Oort IM, Coenen JLLM, van den Bergh ACMF, Mehra N, Somford DM, Bergman AM, Ten Bokkel Huinink D, Fossion L, Geenen MM, Hendriks MP, van de Luijtgaarden ACM, Polee MB, Weijl NI, van de Wouw AJ, de Wit R, Uyl-de Groot CA, Gerritsen WR. Kuppen MCP, et al. Among authors: van oort im, van den eertwegh ajm, van de wouw aj, van den bergh acmf, van de luijtgaarden acm, van moorselaar rja. Eur Urol Oncol. 2021 Aug;4(4):618-627. doi: 10.1016/j.euo.2019.09.005. Epub 2019 Oct 8. Eur Urol Oncol. 2021. PMID: 31601523
Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study.
Rijksen BLT, Pos FJ, Hulshof MCCM, Vernooij RWM, Jansen H, van Andel G, Wijsman BP, Somford DM, Busstra MB, van Moorselaar RJA, Kaa CAH, van Leenders GJLH, Hamberg P, van den Berkmortel F, Fütterer JJ, Kiemeney LA, van Oort IM, Aben KKH. Rijksen BLT, et al. Among authors: van oort im, van andel g, van den berkmortel f, van moorselaar rja, van leenders gjlh. Eur Urol Focus. 2021 Mar;7(2):332-339. doi: 10.1016/j.euf.2019.11.005. Epub 2019 Nov 17. Eur Urol Focus. 2021. PMID: 31748122 Review.
Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy.
Jansen BHE, van Leeuwen PJ, Wondergem M, van der Sluis TM, Nieuwenhuijzen JA, Knol RJJ, van Moorselaar RJA, van der Poel HG, Oprea-Lager DE, Vis AN. Jansen BHE, et al. Among authors: van der sluis tm, van leeuwen pj, van moorselaar rja, van der poel hg. Eur Urol Oncol. 2021 Oct;4(5):821-825. doi: 10.1016/j.euo.2020.01.002. Epub 2020 Feb 20. Eur Urol Oncol. 2021. PMID: 32088155
Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer.
Cysouw MCF, Jansen BHE, van de Brug T, Oprea-Lager DE, Pfaehler E, de Vries BM, van Moorselaar RJA, Hoekstra OS, Vis AN, Boellaard R. Cysouw MCF, et al. Among authors: van de brug t, van moorselaar rja. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):340-349. doi: 10.1007/s00259-020-04971-z. Epub 2020 Jul 31. Eur J Nucl Med Mol Imaging. 2021. PMID: 32737518 Free PMC article.
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial.
Jansen BHE, Bodar YJL, Zwezerijnen GJC, Meijer D, van der Voorn JP, Nieuwenhuijzen JA, Wondergem M, Roeleveld TA, Boellaard R, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN. Jansen BHE, et al. Among authors: van moorselaar rja, van der voorn jp. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):509-520. doi: 10.1007/s00259-020-04974-w. Epub 2020 Aug 12. Eur J Nucl Med Mol Imaging. 2021. PMID: 32789599 Free PMC article. Clinical Trial.
Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands.
Kuppen MCP, Westgeest HM, van den Eertwegh AJM, van Moorselaar RJA, van Oort IM, Tascilar M, Mehra N, Lavalaye J, Somford DM, Aben KKH, Bergman AM, de Wit R, van den Bergh ACMF, de Groot CAU, Gerritsen WR. Kuppen MCP, et al. Among authors: van oort im, van den eertwegh ajm, van den bergh acmf, van moorselaar rja. Clin Genitourin Cancer. 2022 Feb;20(1):43-52. doi: 10.1016/j.clgc.2021.10.008. Epub 2021 Nov 2. Clin Genitourin Cancer. 2022. PMID: 34848157 Free article.
175 results